ORYZF Message Board Post 9880774 | Oryzon Genomics S.A.
home / stock / oryzf / oryzf message board
patrickmuenzen
(investorshub)
Posted on: Dec/22/2016 16:40:32
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=127364385
Oryzon sube un 40% tras anunciar resultados clnicos
News, Short Squeeze, Breakout and More Instantly...
Oryzon Genomics S.A. Company Name:
ORYZF Stock Symbol:
Market:
-
Data from the first two cohorts demonstrated that combination of iadademstat plus gilteritinib was safe and showed strong antileukemic activity A third cohort is ongoing following FDA’s OPTIMUS guidance MADRID and CAMBRIDGE, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- Oryzon G...
-
The Phase IIa study ALICE evaluated the combination of iadademstat plus azacitidine in newly diagnosed, unfit patients with acute myeloid leukemia (AML) The combination showed substantial antileukemic activity with deep responses and a manageable safety profile, including in patients with...
-
BIO International Convention 2024 European Hematology Association (EHA) 2024 European Network to Cure ALS (ENCALS) 2024 MADRID and CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical ...